Inventor · disambiguated record
Estelle Trifilieff
Also filed as: TRIFILIEFF ESTELLE
4 granted patents·8 pending applications·78 citations·filing 2010–2024
77Inventor score
Top patents by PatentIndex Score
12 records- 0191US8388968B2Compositions and methods for increasing muscle growthBERGER CATRIN·Filed 2010·Granted Mar 5, 2013·66 cites·34 claims
- 0284US2024425602A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0379US8551482B2Compositions and methods for increasing muscle growthBERGER CATRIN·Filed 2012·Granted Oct 8, 2013·6 cites·18 claims
- 0474US11357851B2Uses of myostatin antagonists, combinations containing them and uses thereofNOVARTIS AG·Filed 2016·Granted Jun 14, 2022·2 cites·11 claims
- 0571US9365651B2Method for treating metabolic disorders by administration of an anti-ActRIIB antibodyFEIGE JEROME·Filed 2012·Granted Jun 14, 2016·4 cites·10 claims
- 0661US2018194846A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0761US2022265823A1Uses of myostatin antagonists, combinations containing them and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0857US2013344091A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2013·Application pending·0 cites
- 0954US2018134791A9Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1042US2020181271A1Methods for preventing and treating urinary incontinenceNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1140US2022340668A1Treatment of liver disease or disorder comprising actrii receptor antagonistsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1229US2017260275A1Myostatin or activin antagonists for the treatment of sarcopeniaNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Estelle Trifilieff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →